GO:0046627 negative regulation of insulin receptor signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046627 describes any process that stops, prevents, or reduces the frequency, rate or extent of insulin receptor signaling.
• Negative regulation is essential for preventing excessive insulin action and is mediated by phosphatases, kinases, and feedback loops that modify IRS proteins and the insulin receptor.
• Dysregulated negative regulation contributes to insulin resistance, type 2 diabetes, obesity, and aging-related metabolic decline.
• Key negative regulators include PTP1B, PTEN, SHIP2, SOCS proteins, and mTORC2-driven feedback phosphorylation of IRS-1.
• CRISPR knockout, point mutation, and knock-in models enable precise dissection of negative feedback nodes in insulin signaling.
• Understanding this process informs therapeutic strategies for diabetes, cancer, and neurodegenerative conditions linked to insulin resistance.
Description
Insulin receptor signaling is a fundamental pathway that controls glucose uptake, lipid synthesis, protein translation, and cell survival. To maintain metabolic homeostasis, this pathway must be tightly restrained; otherwise, sustained insulin stimulation would lead to cellular desensitization and pathological outcomes. The Gene Ontology term GO:0046627, negative regulation of insulin receptor signaling pathway, captures the diverse molecular events that attenuate or terminate insulin receptor signaling. These events include dephosphorylation of the insulin receptor and its substrates, proteasomal degradation of IRS proteins, and feedback phosphorylation by downstream kinases such as mTORC2 and S6K. Researchers study GO:0046627 because its dysregulation is a hallmark of insulin resistance, a condition that precedes type 2 diabetes and is associated with obesity, cardiovascular disease, and neurodegeneration. In model organisms such as Caenorhabditis elegans, positive and negative feedback loops in insulin-like signaling control lifespan and stress resistance. In mammals, negative regulators like PTP1B and PTEN are validated drug targets for diabetes and cancer. Thus, defining the components and mechanisms of negative regulation is critical for understanding metabolic disease and for developing targeted therapies.
negative regulation of insulin receptor signaling pathway At A Glance
| GO ID | GO:0046627 |
|---|---|
| GO term | negative regulation of insulin receptor signaling pathway |
| Ontology | biological_process |
| Synonym | inhibition of insulin receptor signaling pathway; downregulation of insulin receptor signaling pathway; negative regulation of insulin receptor signalling pathway |
| Major function | Attenuation or termination of insulin receptor signaling to prevent excessive metabolic and mitogenic responses |
| Key regulators | PTP1B, PTEN, SHIP2, SOCS1/3, GRB10, mTORC2, S6K, ERK |
| Cellular context | Cytoplasm, plasma membrane, endosomes; affects IRS-1/2 phosphorylation and degradation |
| Physiological impact | Controls glucose homeostasis, insulin sensitivity, and aging-related pathways |
What Is GO:0046627?
GO:0046627, negative regulation of insulin receptor signaling pathway, is defined as any biological process that stops, prevents, or reduces the frequency, rate or extent of insulin receptor signaling. This includes mechanisms that act directly on the insulin receptor or its immediate substrates, such as IRS-1 and IRS-2, to dampen downstream signal transduction.
Why Is negative regulation of insulin receptor signaling pathway Important in Cell Biology?
Negative regulation of insulin receptor signaling is essential for metabolic homeostasis; without it, cells become desensitized to insulin, leading to hyperglycemia and compensatory hyperinsulinemia. This process also intersects with aging, oxidative stress, and nutrient-sensing pathways, making it a central node in age-related diseases.
• Prevents insulin resistance by terminating acute insulin signals.
• Controls glucose uptake and lipid metabolism in liver, muscle, and adipose tissue.
• Modulates lifespan and stress responses in model organisms.
• Links insulin signaling to oxidative stress and aging.
• Involved in cancer biology through PTEN and other negative regulators.
• Provides therapeutic targets for type 2 diabetes and metabolic syndrome.
• Regulates central nervous system functions such as feeding behavior.
• Essential for feedback inhibition by mTORC2 and S6K.
What Happens During negative regulation of insulin receptor signaling pathway?
Dephosphorylation of the Insulin Receptor and IRS Proteins
In simple terms: Phosphatases remove phosphate groups from the insulin receptor and its substrates, turning off the signal.
Protein tyrosine phosphatases such as PTP1B dephosphorylate the insulin receptor and IRS-1, reducing their ability to recruit downstream effectors like PI3K. This is a major mechanism of negative regulation in vivo, as PTP1B knockout mice show enhanced insulin sensitivity.
Serine/Threonine Phosphorylation of IRS-1
In simple terms: Kinases add phosphate groups to IRS-1 at specific serine/threonine sites, which weakens insulin signaling.
Feedback phosphorylation of IRS-1 by mTORC2, S6K, ERK, and JNK impairs its tyrosine phosphorylation and promotes its degradation, thereby attenuating insulin action. This negative feedback loop is a key node in insulin resistance.
Proteasomal Degradation of IRS Proteins
In simple terms: Tagged IRS proteins are destroyed by the proteasome, reducing the cell's ability to respond to insulin.
Serine phosphorylation of IRS-1 can trigger its ubiquitination and proteasomal degradation, a process that contributes to sustained insulin resistance. This mechanism is regulated by SOCS proteins and other E3 ligases.
Lipid Phosphatase Action by PTEN and SHIP2
In simple terms: PTEN and SHIP2 remove phosphate groups from PIP3, a lipid messenger that insulin uses to activate downstream signals.
PTEN dephosphorylates PIP3 to PIP2, while SHIP2 converts PIP3 to PIP2 via a different route, both reducing AKT activation. These phosphatases are critical negative regulators of insulin signaling and are frequently altered in cancer and diabetes.
Feedback Regulation by mTORC2 and S6K
In simple terms: mTORC2 and S6K act as brakes on insulin signaling by phosphorylating IRS-1.
mTORC2 phosphorylates IRS-1 at serine residues, leading to reduced insulin-stimulated AKT activation. This negative feedback loop prevents overactivation of the pathway and is disrupted in obesity and type 2 diabetes.
Key Genes Involved in GO:0046627 negative regulation of insulin receptor signaling pathway
The following genes and proteins are central to the negative regulation of insulin receptor signaling, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PTPN1 (PTP1B) | Dephosphorylates insulin receptor and IRS-1 | Major drug target for diabetes and obesity |
| PTEN | Lipid phosphatase that converts PIP3 to PIP2 | Tumor suppressor; negative regulator of insulin signaling |
| INPPL1 (SHIP2) | Converts PIP3 to PIP2 | Modulates insulin sensitivity; linked to diabetes |
| IRS1 | Substrate of insulin receptor; negative feedback target | Serine phosphorylation impairs insulin signaling |
| IRS2 | Substrate of insulin receptor; negative feedback target | Regulates beta-cell survival and glucose homeostasis |
| SOCS1 | E3 ligase adaptor; promotes IRS degradation | Involved in cytokine-induced insulin resistance |
| SOCS3 | E3 ligase adaptor; promotes IRS degradation | Linked to obesity and inflammation |
| GRB10 | Adaptor protein that inhibits insulin receptor | Negative regulator of insulin action |
| MTOR | Kinase in mTORC2 that phosphorylates IRS-1 | Central to feedback inhibition |
| RPS6KB1 (S6K) | Phosphorylates IRS-1 at serine sites | Mediates nutrient feedback to insulin signaling |
| MAPK1 (ERK2) | Phosphorylates IRS-1 at serine sites | Contributes to negative feedback |
| MAPK3 (ERK1) | Phosphorylates IRS-1 at serine sites | Contributes to negative feedback |
| JNK1 | Stress kinase that phosphorylates IRS-1 | Links inflammation to insulin resistance |
| PRKAA1 (AMPK) | Energy sensor; can inhibit mTORC1 | Modulates insulin sensitivity |
| TSC2 | Inhibits mTORC1; upstream of feedback | Tumor suppressor; affects insulin signaling |
| RPTOR | Component of mTORC1; regulates S6K | Feedback regulation of insulin signaling |
| RICTOR | Component of mTORC2; phosphorylates IRS-1 | Direct negative feedback on insulin signaling |
How Is negative regulation of insulin receptor signaling pathway Regulated?
The negative regulation of insulin receptor signaling is itself regulated by nutrient and hormonal cues. mTORC2 and S6K are activated by insulin and nutrients, and they phosphorylate IRS-1 to dampen further insulin signaling. AMPK, an energy sensor, can inhibit mTORC1 and reduce feedback inhibition, thereby enhancing insulin sensitivity. In C. elegans, insulin-like signaling is subject to pervasive positive and negative feedback, which controls lifespan and stress resistance. Additionally, oxidative stress and inflammatory cytokines can activate JNK and SOCS proteins, which promote IRS-1 serine phosphorylation and degradation, linking metabolic stress to insulin resistance.
negative regulation of insulin receptor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTPN1 | Type 2 diabetes, obesity | Knockout mouse, liver-specific KO |
| PTEN | Cancer, insulin resistance | Conditional KO, point mutation knock-in |
| IRS1 | Insulin resistance, diabetes | Serine-to-alanine point mutation knock-in |
| MTOR | Metabolic syndrome, cancer | Kinase-dead knock-in, conditional KO |
| SOCS3 | Obesity, inflammation | Overexpression and KO models |
Type 2 Diabetes and Insulin Resistance
Impaired negative regulation of insulin receptor signaling contributes to insulin resistance, a hallmark of type 2 diabetes. Increased serine phosphorylation of IRS-1 by mTORC2, S6K, and JNK reduces insulin-stimulated glucose uptake. PTP1B overexpression dephosphorylates the insulin receptor, further blunting insulin action.
Obesity and Metabolic Syndrome
Obesity is associated with chronic inflammation and elevated cytokine levels that activate SOCS proteins and JNK, leading to enhanced negative regulation of insulin signaling. Central amygdala dopamine D2 receptor modulation of insulin receptor signaling has been implicated in compulsive-like eating behavior, linking negative regulation to feeding control.
Aging and Oxidative Stress
Aberrant insulin receptor signaling and amino acid homeostasis contribute to oxidative stress during aging. Negative regulators such as PTEN and PTP1B influence lifespan in model organisms, and their dysregulation is linked to age-related metabolic decline.
Cancer
PTEN is a major tumor suppressor that negatively regulates insulin signaling by dephosphorylating PIP3. Loss of PTEN leads to hyperactivation of the PI3K/AKT pathway, promoting cancer cell growth and survival.
From negative regulation of insulin receptor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PTP1B enhance insulin sensitivity? | PTPN1 knockout mouse or cell line |
| What is the role of IRS-1 serine phosphorylation in feedback? | IRS1 serine-to-alanine knock-in |
| How does mTORC2 phosphorylate IRS-1? | RICTOR knockout or kinase-dead knock-in |
| Does PTEN loss drive insulin hypersensitivity? | PTEN conditional knockout |
| How does S6K feedback affect glucose homeostasis? | RPS6KB1 knockout or overexpression |
| What is the impact of SOCS3 on insulin signaling? | SOCS3 overexpression and knockout |
How to Study the negative regulation of insulin receptor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphoproteomics | Global phosphorylation changes | Identify feedback phosphorylation sites on IRS-1 |
| Western blot | Specific protein phosphorylation | Validate insulin receptor and AKT activation |
| Glucose uptake assay | Functional insulin sensitivity | Assess PTP1B or PTEN knockout effects |
| CRISPR knockout screen | Gene essentiality for negative regulation | Discover novel regulators |
| Co-immunoprecipitation | Protein-protein interactions | Study insulin receptor-IRS complexes |
| RNA-seq | Transcriptional changes | Measure feedback gene expression |
| Proteasome activity assay | IRS-1 degradation rate | Evaluate SOCS-mediated degradation |
| In vivo glucose tolerance test | Whole-body insulin sensitivity | Validate mouse models |
Phosphoproteomics
Mass spectrometry-based phosphoproteomics can quantify changes in phosphorylation of the insulin receptor, IRS-1, and downstream effectors upon manipulation of negative regulators.
Western Blotting and Immunoprecipitation
Standard immunoblotting for phospho-insulin receptor, phospho-AKT, and phospho-IRS-1 (serine sites) is used to assess negative regulation.
Glucose Uptake Assays
Radiolabeled or fluorescent glucose uptake assays in adipocytes and myotubes measure the functional consequence of altered negative regulation.
CRISPR Screens
Genome-wide CRISPR knockout screens can identify novel negative regulators of insulin signaling by selecting for cells with enhanced or reduced insulin sensitivity.
How CRISPR Can Be Used to Study GO:0046627 negative regulation of insulin receptor signaling pathway
Knockout
CRISPR knockout of negative regulators such as PTPN1, PTEN, or SOCS3 can enhance insulin sensitivity, providing causal evidence for their roles. These models are valuable for target validation in diabetes research.
Point Mutation
Point mutations in IRS1 at serine phosphorylation sites (e.g., Ser307 to Ala) can prevent feedback inhibition, allowing precise dissection of negative regulation. CRISPR-mediated knock-in of these mutations is a powerful approach.
Knock-in
Knock-in of tagged versions of insulin receptor or IRS-1 (e.g., HA or GFP) enables live-cell imaging and interaction studies. This helps track the dynamics of negative regulation.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of negative regulators like PTP1B or PTEN can induce insulin resistance in cell models, mimicking disease states.
How EDITGENE Supports negative regulation of insulin receptor signaling pathway Research
Researchers studying negative regulation of insulin receptor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in dampening insulin action. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of insulin receptor signaling pathway research.
Frequently Asked Questions About negative regulation of insulin receptor signaling pathway
What is negative regulation of insulin receptor signaling pathway?
It is any process that stops, prevents, or reduces insulin receptor signaling, as defined by GO:0046627.
What genes are involved in negative regulation of insulin receptor signaling?
Key genes include PTPN1, PTEN, INPPL1, SOCS1, SOCS3, GRB10, MTOR, RPS6KB1, and IRS1.
How does PTP1B negatively regulate insulin signaling?
PTP1B dephosphorylates the insulin receptor and IRS-1, reducing their ability to activate downstream effectors.
What is the role of PTEN in insulin signaling?
PTEN dephosphorylates PIP3 to PIP2, thereby reducing AKT activation and acting as a negative regulator.
How does mTORC2 feedback inhibit insulin signaling?
mTORC2 phosphorylates IRS-1 at serine residues, which impairs insulin-stimulated AKT activation.
What diseases are linked to dysregulated negative regulation of insulin signaling?
Type 2 diabetes, obesity, cancer, and aging-related metabolic decline.
How can CRISPR be used to study negative regulation of insulin signaling?
CRISPR knockout, point mutation knock-in, and overexpression models allow precise manipulation of negative regulators.
What are the main mechanisms of negative regulation?
Dephosphorylation by phosphatases, serine phosphorylation of IRS-1, proteasomal degradation of IRS proteins, and lipid phosphatase action.
Is negative regulation of insulin signaling conserved in model organisms?
Yes, in C. elegans, insulin-like signaling is subject to positive and negative feedback that controls lifespan.
What experimental methods are used to study this process?
Phosphoproteomics, Western blotting, glucose uptake assays, and CRISPR screens.
Conclusion
GO:0046627, negative regulation of insulin receptor signaling pathway, encompasses critical molecular brakes that prevent excessive insulin action. These mechanisms, including phosphatase activity, serine phosphorylation of IRS-1, and proteasomal degradation, are essential for metabolic homeostasis. Dysregulation of these processes contributes to insulin resistance, diabetes, cancer, and aging. CRISPR-based models offer powerful tools to dissect these pathways and identify therapeutic targets.
References
- 1. Boucher J et al.. 2014. Insulin receptor signaling in normal and insulin-resistant states.. Cold Spring Harb Perspect Biol 6(1) PMID: 24384568
- 2. Gual P et al.. 2005. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.. Biochimie 87(1):99-109 PMID: 15733744
- 3. Kaplan REW et al.. 2019. Pervasive Positive and Negative Feedback Regulation of Insulin-Like Signaling in Caenorhabditis elegans.. Genetics 211(1):349-361 PMID: 30425043
- 4. Dröge W et al.. 2008. Aberrant insulin receptor signaling and amino acid homeostasis as a major cause of oxidative stress in aging.. Antioxid Redox Signal 10(4):661-78 PMID: 18162053
- 5. Kim B et al.. 2026. Dopamine D2 receptor modulation of insulin receptor signaling in the central amygdala: implications for compulsive-like eating behavior.. Mol Psychiatry 31(2):664-675 PMID: 40885844
- 6. Destefano MA et al.. 2013. Regulation of insulin receptor substrate-1 by mTORC2 (mammalian target of rapamycin complex 2).. Biochem Soc Trans 41(4):896-901 PMID: 23863152
- 7. Goldstein BJ et al.. 2005. Role of insulin-induced reactive oxygen species in the insulin signaling pathway.. Antioxid Redox Signal 7(7-8):1021-31 PMID: 15998257
- 8. Sun XJ et al.. 2009. Phosphorylation of IRS proteins Yin-Yang regulation of insulin signaling.. Vitam Horm 80:351-87 PMID: 19251044
